These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 10146554

  • 1. Clinical applications of hematopoietic growth factors.
    Williams L.
    Clin Lab Sci; 1993; 6(5):283-90. PubMed ID: 10146554
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y.
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [Abstract] [Full Text] [Related]

  • 6. Haematopoietic growth factors and their therapeutic use.
    Wadhwa M, Thorpe R.
    Thromb Haemost; 2008 May; 99(5):863-73. PubMed ID: 18449415
    [Abstract] [Full Text] [Related]

  • 7. Cytokines in the treatment of hematological disorders: recent progress and perspectives.
    Robak T.
    Arch Immunol Ther Exp (Warsz); 1996 May; 44(1):5-9. PubMed ID: 8874763
    [Abstract] [Full Text] [Related]

  • 8. Transfusion support of hematology and oncology patients. The role of recombinant hematopoietic growth factors.
    Cottler-Fox M, Klein HG.
    Arch Pathol Lab Med; 1994 Apr; 118(4):417-20. PubMed ID: 7909429
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical applications of the hematopoietic growth factors.
    Rowland P, Mirro J.
    Curr Opin Hematol; 1994 Jul; 1(4):303-9. PubMed ID: 9371297
    [Abstract] [Full Text] [Related]

  • 11. Hematopoiesis and growth factors in elderly cancer patients.
    Tafuri A, Mandelli F.
    Rays; 1997 Jul; 22(1 Suppl):37-41. PubMed ID: 9250012
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M, Shirakawa T.
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [Abstract] [Full Text] [Related]

  • 14. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 15. [Recombinant hematopoietic growth factors in the treatment of various hematologic diseases].
    Pawelski S.
    Acta Haematol Pol; 1991 May; 22(1):186-93. PubMed ID: 1823962
    [No Abstract] [Full Text] [Related]

  • 16. [Hematopoietic growth factors in oncology and hematology. Recommendations for more cost-efficient use].
    Paul C, Hast R.
    Lakartidningen; 2000 Jun 07; 97(23):2862-6. PubMed ID: 10885223
    [No Abstract] [Full Text] [Related]

  • 17. Stimulating new developments. Colony-stimulating factors.
    Kare D.
    J Intraven Nurs; 1993 Jun 07; 16(1):37-43. PubMed ID: 8437044
    [Abstract] [Full Text] [Related]

  • 18. Homing efficiency and hematopoietic reconstitution of bone marrow-derived stroma cells expanded by recombinant human macrophage-colony stimulating factor in vitro.
    Jin-Xiang F, Xiaofeng S, Jun-Chuan Q, Yan G, Xue-Guang Z.
    Exp Hematol; 2004 Dec 07; 32(12):1204-11. PubMed ID: 15588945
    [Abstract] [Full Text] [Related]

  • 19. [Hematopoietic stem cells].
    Vainchenker W.
    Therapie; 2001 Dec 07; 56(4):379-81. PubMed ID: 11677857
    [Abstract] [Full Text] [Related]

  • 20. Future directions with hematopoietic growth factors.
    Vadhan-Raj S.
    J Natl Compr Canc Netw; 2003 Jan 07; 1 Suppl 1():S96-101. PubMed ID: 19795582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.